Acadia Pharmaceuticals Appoints Carl Segerstrom as Chief People Officer
DAYBU® (trofinetide) Recommended for Approval in the European Union by CHMP
Acadia Pharmaceuticals Reports First Quarter 2026 Financial Results and Reaffirms 2026 Financial Guidance